51. Manninen, V., "Tablet Disintegration: Possible Link with Biological Availability of Digoxin," The Lancet, p. 490, Feb. 26, 1972.

52.

53.

54.

Cohen, N. A., "The Plasma-Digoxin Controversy," The Lancet, pp. 535-537,
March 4, 1972.

Levy, R. H., P. M. Lutterbeck and J. Lindenbaum, "Digoxin," The New England
Journal of Medicine (letters to the editor), pp. 666-667, March 23, 1972.

Butler, V. P., Jr., "Assays of Digitalis in the Blood," Progress

in Cardiovascular Diseases, XIV, No. 6:571-600, 1972.

55. Butler, V. P., "Practical Aspects of Immunological Assays,'

Medical Times, pp. 59-76, May 1972.

56. Livanou, T., E. Voridis, K. Kaplanidis and C. J. Miras, "Digitalis

Toxicity," The Lancet, p. 1027, May 6, 1972.

57. Phillips, A. P., "Sources of Error in Radioimmunoassays," The

Lancet, pp. 1183-1184, May 27, 1972.

58. Hibble, A. G., P. Isaac and D. G. Grahame-Smith, "Bioavailability

of Digoxin," The Lancet, pp. 90-91, July 8, 1972.

59. Smith, T. W., "Contribution of Quantitative Assay Technics to the

60.

61.

Understanding of the Clinical Pharmacology of Digitalis," Circulation,
XLVI:188-199, 1972.

Shapiro, W., K. Taubert and K. Narahara, "Nonradioactive Serum

Digoxin and Digitoxin Levels," Archives of Internal Medicine,
130:31-36, 1972.

Hamer, J. and D. G. Grahame-Smith, "Bioavailability of Digoxin,"
The Lancet, p. 325, Aug. 12, 1972.

62.

63.

64.

Ellis, J. L., D. Pickering and W. Trillwood, "Digitalisation of
Infants," The Lancet, p. 325, Aug. 12, 1972.

Kolendorf, K., N. J. B. Christiansen, L. Siersback-Nielsen and
J. M. Hansen, "Serum-digoxin After Dosage Regimen Based on Body-
weight and Renal Function," The Lancet, p. 326, Aug. 12, 1972.
Kuno-Sakai, H., H. Sakai and S. E. Ritzmann, "Interference of

Digitoxin with the Radioimmunoassay of Digoxin," The Lancet, p. 326-327,
Aug. 12, 1972.

65. Shaw, T. R. D., M. R. Howard and J. Hamer, "Variation in the

Biological Availability of Digoxin," The Lancet, pp. 303-307, Aug. 12,

1972.

66. "The Bioavailability of Digoxin," The Lancet (editorial), pp. 311312, Aug. 12, 1972.

67.

68.

69.

70.

71.

Binnion, P. F. and M. McDermott, "Bioavailability of Digoxin,'

The Lancet (letters to the editor), p. 592, Sept. 16, 1972.

"Bioavailability and Digoxin," New Zealand Medical Journal

(editorial), 76:203, Sept. 1972.

Graser, E. J., R. H. Leach and J. W. Poston, "Bioavailability of

Digoxin," The Lancet, p. 541, Sept. 9, 1972.

Stewart, M. J. and E. Simpson, "New Formulation of Lanoxin;

Expected Plasma Levels of Digoxin," The Lancet, p. 541, Sept. 9, 1972.

Butler, V. P., Jr., "Practical Aspects of Immunological Assays,"
Resident and Staff Physician, pp. 46-55, Sept. 1972.

72. Krasula, R. W., P. A. Pellegrimo, A. R. Hastrieter and L. F. Soyka, "Serum Levels of Digoxin in Infants and Children," Journal of

Pediatrics, 81, No. 3:566-569, 1972.

73. Beller, G. A., T. W. Smith and W. B. Hood, Jr., "Altered Distribution

74.

75.

76.

77.

78.

of Tritiated Digoxin in the Infarcted Canine Left Ventricle,"
Circulation, XLVI:572-579, 1972.

Kalman, S. M., "Bioavailability of Digoxin," The Lancet (letters to
the editor), p. 593, Sept. 16, 1972.

Doherty, J. E., J. K. Bissett and T. E. Ratts, "Bioavailability of
Digoxin," The Lancet (letters to the editor), p. 593, Sept. 16, 1972.
Bertler, A., A. Redfors, S. Medin and L. Nyberg, "Bioavailability
of Digoxin," The Lancet, p. 708, Sept. 30, 1972.

Shaw, T. R. D. and M. R. Howard, "Value of Plasma-Digoxin
Estimation," The Lancet, pp. 770-771, Oct. 7, 1972.

Ewy, G. A., "Digitalis Therapy in the Geriatric Patient," Drug
Therapy, pp. 36-49, Oct. 1972.

79. Manninen, V., K. Ojala and P. Reissell, "New Formulation of

80.

Digoxin," The Lancet, pp. 922-923, Oct. 28, 1972.

Stoll, R. G., M. S. Christensen, E. Sakmar and J. G. Wagner,

"The Specificity of the Digoxin Radioimmunoassay Procedure,'
Research Communications in Chemical Pathology and Pharmacology,
4, No. 3:503-510, 1972.

Huffman, D. H. and D. L. Azarnoff, "Absorption of Orally Given

Digoxin Preparations," Journal of the American Medical Association, 222, No. 8:957-960, 1972.

Meade, R. C. and T. J. Kleist, "Improved Radioimmunoassay of Digoxin and Other Sterol-like Compounds Using Somogyi Precipitation,"

Journal of Laboratory and Clinical Medicine, 80:748-754, 1972. 83. Hobson, J. D. and A. Zettner, "Digoxin Serum Half-life Following Suicidal Digoxin Poisoning," Journal of the American Medical

Association, 223, No. 2:147-149, 1973.

Smith, T. W., "Digitalis Glycosides (First of Two Parts)," New
England Journal of Medicine, 228, No. 14:719-722,

1973.

85. Sorby, D. L. and T. N. Tozer, "On the Evaluation of Biologic Availability of Digoxin from Tablets," Drug Intelligence and Clinical Pharmacology, 7:78-83, 1973.

86.

Burnett, G. H., R. L. Conklin, G. W. Wasson and A. A. MacKinney,
"Variability of Standard Curves in Radioimmunoassay of Plasma
Digoxin," Clinical Chemistry, 19, No. 7:725-726, 1973.

87. Vieweg, W. V. R. and J. Sode, "Evaluation of Biologic Availability of Digoxin Preparations Available to a Naval Hospital," Medical Annals of the District of Columbia, 42, No. 3:136-140, 1973.

88.

Skelly, J. P. and G. Knapp, "Biologic Availability of Digoxin Tablets," Journal of the American Medical Association (editorial), 224, No. 2:243, 1973.

"Discordances of Digoxin," Journal of the American Medical

Association (editorial), 224, No. 2:243-244, 1973.

90. Wagner, J. G., M. Christensen, E. Sakmar, D. Blair, J. Yates,
P. W. Willis III, A. J. Sedman and R. G. Stoll, "Equivalence
Lack in Digoxin Plasma Levels," Journal of the American Medical
Association, 224, No. 2:199-204, 1973.

91.

Binnion, P. F., M. McDermott and D. LeSher, "Bioavailability of
Digoxin," The Lancet, p. 1118, May 19, 1973.

92. Smith, T. W., "Digitalis Glycosides (Second of Two Parts),"

The New England Journal of Medicine, 288, No. 18:942-946, 1973. 93. Manninen, V., A. Apajalahti, H. Simonen and R. Reissel, "Effect of Propantheline and Metoclopramide on Absorption of Digoxin," The

Lancet, p. 1119, May 19, 1973.

94. Lindenbaum, J., "Bioavailability of Digoxin Tablets," Pharmacological

Reviews, 25, No. 2:229-237, 1973.

Lindenbaum, J., V. P. Butler, Jr., J. E. Murphy and R. M. Cresswell,

"Correlation of Digoxin-Tablet Dissolution-Rate with Biological
Availability," The Lancet, pp. 1215-1217, June 2, 1973.

96. Doluisio, J., D. Fedder, G. Manley, T. Mattei, C. Nightengale and

W. Barr, "Report of the Ad Hoc Committee on Drug Product Selection of
the Academy of General Practice of Pharmacy and the Academy of

Pharmaceutical Sciences," Journal of the American Pharmaceutical
Association, N513, No. 6:278-280, 1973.